Skip to main content

26 August 2026

Last updated: Monday 24 August 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Developing radionuclide PARP inhibitors

Sunday 22 November 2020

Interviewee/Contributor

Greg Mullen

Organisation

Theragnostics Ltd

Organisations

Vertex Pharmaceuticals Inc
Sidley Austin LLP
Biotec Pharmacon ASA
Molecular Health GmbH
iOnctura BV
McKenna, Long & Aldridge
IsomAb Ltd
CEPI
BioLizard NV
C4X Discovery Ltd

Interviewees and Contributers

Harren Jhoti
Lars Rebien Sørensen
Kevin Johnson
David Mott
Christian Grøndahl
Jónas Einarsson
Stuart Naylor
Andy Smith
Michael Dabrowski
Julian Hitchcock

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

ViCentra appoints CFO and adds a board member

Wednesday 22 July 2026

New CEO at Simris Biologics

Wednesday 22 July 2026

New CEO at Genopore

Wednesday 22 July 2026

Camena Bioscience appoints CEO

Wednesday 22 July 2026

Lundbeck promotes research head to EVP R&D

Wednesday 22 July 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form